Biostar Pharmaceuticals, Inc. Advertising Expense
Biostar Pharmaceuticals, Inc. reported Advertising Expense of $3.20 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2017-05-19
- Biostar Pharmaceuticals, Inc. advertising expense for the quarter ending 2017-03-31 was $3.20M.
- Biostar Pharmaceuticals, Inc. advertising expense for the quarter ending 2012-12-31 was $2.90M, a 53.97% decline year-over-year.
- Biostar Pharmaceuticals, Inc. advertising expense for the quarter ending 2012-09-30 was $4.10M, a 28.07% decline year-over-year.
- Biostar Pharmaceuticals, Inc. advertising expense for the quarter ending 2011-12-31 was $6.30M.
- Biostar Pharmaceuticals, Inc. advertising expense for fiscal 2015 was $3.80M, a 55.81% decline from fiscal 2014.
- Biostar Pharmaceuticals, Inc. advertising expense for fiscal 2014 was $8.60M, a 13.16% increase from fiscal 2013.
- Biostar Pharmaceuticals, Inc. advertising expense for fiscal 2013 was $7.60M, a 46.48% decline from fiscal 2012.
- Biostar Pharmaceuticals, Inc. advertising expense for fiscal 2012 was $14.20M, a 33.02% decline from fiscal 2011.
| Period end | Advertising Expense 3 month | Advertising Expense 6 month | Advertising Expense 9 month | Advertising Expense 12 month | Advertising Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2017-03-31 | $3.20M 10-Q · filed 2017-05-19 | ||||
| 2016-12-31 | $3.20M 10-Q · filed 2017-05-19 | $0.00 10-K · filed 2017-04-13 | |||
| 2015-12-31 | $3.80M 10-K · filed 2017-04-13 | ||||
| 2014-12-31 | $8.60M 10-K · filed 2016-04-14 | ||||
| 2013-12-31 | $7.60M 10-K · filed 2015-04-15 | ||||
| 2012-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $7.00M derived: sum of 2 quarters · filed 2014-03-31 | $14.20M 10-K · filed 2014-03-31 | ||
| 2012-09-30 | $4.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-19 | $11.30M 10-Q · filed 2012-11-19 | |||
| 2012-06-30 | $7.20M 10-Q · filed 2012-08-14 | ||||
| 2011-12-31 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15 | $12.00M derived: sum of 2 quarters · filed 2013-04-15 | $21.20M 10-K · filed 2013-04-15 | ||
| 2011-09-30 | $5.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-19 | $14.90M 10-Q · filed 2012-11-19 | |||
| 2011-06-30 | $9.20M 10-Q · filed 2012-08-14 |